A detailed history of Howland Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Howland Capital Management LLC holds 1,489 shares of VRTX stock, worth $748,148. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,489
Previous 836 78.11%
Holding current value
$748,148
Previous $349,000 99.71%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $256,504 - $317,051
653 Added 78.11%
1,489 $697,000
Q1 2024

May 03, 2024

SELL
$407.69 - $446.08 $55,853 - $61,112
-137 Reduced 14.08%
836 $349,000
Q4 2023

Jan 23, 2024

SELL
$343.0 - $410.68 $16,464 - $19,712
-48 Reduced 4.7%
973 $395,000
Q3 2023

Oct 17, 2023

SELL
$338.18 - $362.46 $42,272 - $45,307
-125 Reduced 10.91%
1,021 $355,000
Q1 2023

May 05, 2023

BUY
$283.23 - $323.1 $324,581 - $370,272
1,146 New
1,146 $361,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.